NIOX Share Price Performance
UK£0.75
0.07 (10.62%)
Price UK£0.75
Share PriceUK£0.75
NIOX Group Plc Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
NIOX Community Narratives
There are no narratives available yet.
Recent NIOX News & Updates
NIOX Group Plc Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.012
- Gross Margin
- 71.09%
- Net Profit Margin
- 10.65%
- Debt/Equity Ratio
- 0%
NIOX Group Plc Competitors
Snowflake Analysis
About NIOX
- Founded
- 2006
- Employees
- 91
- CEO
- WebsiteView website
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
U.K. Market Performance
- 7 Days: 2.0%
- 3 Months: 7.1%
- 1 Year: 13.2%
- Year to Date: 14.5%
The market has climbed 2.0% in the last 7 days, lead by the Healthcare sector with a gain of 10%. The market is up 13% over the last 12 months. As for the next few years, earnings are expected to grow by 14% per annum. Market details ›